Press Releases

November 6, 2013 • 7:30 AM EST

Amarantus Appoints David A. Lowe, PhD to Board of Directors

October 30, 2013 • 11:31 AM EDT

Amarantus Relocates Headquarters to Janssen Labs @QB3 Incubator in San Francisco

October 16, 2013 • 9:00 AM EDT

Amarantus to Present at 6th Annual Livingston Securities Life Science Stakeholders Summit

October 14, 2013 • 12:09 PM EDT

Amarantus Announces Positive Analytical Performance Data for LymPro Test(R) for Alzheimer's Disease

October 3, 2013 • 8:45 AM EDT

Amarantus Enters Into Letter of Intent With Renishaw for Convection-Enhanced Delivery of MANF in Parkinson's Disease

September 27, 2013 • 6:35 AM EDT

Amarantus Bioscience Holdings Announces 2nd Closing of Private Placement

September 24, 2013 • 8:45 AM EDT

Amarantus to Present at 2013 Aegis Healthcare Conference

September 13, 2013 • 11:17 AM EDT

Amarantus Appoints F. Randall Grimes, MBA as Director of Sponsored Research

September 9, 2013 • 9:53 AM EDT

Amarantus CEO to Present at the 15th Annual Rodman & Renshaw Global Investor Conference

September 4, 2013 • 9:24 AM EDT

Amarantus Bioscience Holdings Announces Private Placement of Convertible Debentures and Warrants